N4P.L Gross Margin

The Gross Margin of N4 Pharma PLC (N4P.L) is 19.13%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

N4P.L Gross Margin - Historical Value

Date	Value
2024-12-31	19.13%
2023-12-31	19.13%

N4P.L Gross Margin - Peers Comparison

Ticker	Name	Value
NUTEX.BD	Nutex Befektetesi Nyrt	100.00%
ZICC.ST	Ziccum AB	7775.20%
ERMA.ST	Enorama Pharma AB	23.48%
FCM.MI	Friulchem SpA	17.99%
HYL.BR	Hyloris Pharmaceuticals SA	97.32%
IRLAB A.ST	IRLAB Therapeutics AB	-44.03%
AMYT.L	Amryt Pharma PLC	3481.68%
EAH.L	ECO Animal Health Group PLC	45.12%
INDEX.ST	InDex Pharmaceuticals Holding AB	-81.95%
ORX.ST	Orexo AB	87.78%
ACPH.BR	Acacia Pharma Group PLC	74.63%
CLBIO.ST	Corline Biomedical AB	137.50%
IBT B.ST	Infant Bacterial Therapeutics AB	7775.20%
AGY.L	Allergy Therapeutics PLC	53.87%
ENZY.ST	Enzymatica AB (publ)	67.40%
MOB.ST	Moberg Pharma AB (publ)	64.37%
OAT.WA	Oncoarendi Therapeutics SA	-26049.80%
KDEV.ST	Karolinska Development AB	-350.07%
LAVI.AT	Lavipharm SA	47.37%
PHO.OL	Photocure ASA	94.15%
PRL.MI	Pierrel SpA	70.15%
SHE.MI	Shedir Pharma Srl Unipersonale	60.29%
OVB.L	Ovoca Bio PLC	7775.20%
RLS.ST	RLS Global AB	-34.31%
ADVIC.PA	Advicenne SA	-49723.60%
LIPI.ST	Lipidor AB	-82.31%
MARI.VI	Marinomed Biotech AG	20.64%
VISTN.OL	Vistin Pharma ASA	64.99%